Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.290
-0.200 (-8.03%)
At close: Dec 27, 2024, 4:00 PM
2.410
+0.120 (5.24%)
After-hours: Dec 27, 2024, 7:53 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $111.93 million as of December 27, 2024. Its market cap has decreased by -86.11% in one year.
Market Cap
111.93M
Enterprise Value
-55.86M
1-Year Change
-86.11%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $111.93M, a decrease of -52.48%. That is a compound annual growth rate of -13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 111.93M | -88.49% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | 335.76M | 42.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 118.58M |
| Inotiv | 117.85M |
| Zomedica | 117.59M |
| American Well | 116.89M |
| Monopar Therapeutics | 116.38M |
| Allakos | 113.47M |
| TELA Bio | 112.65M |
| Cassava Sciences | 112.58M |